The cover illustration shows immunostaining in mucocutane-ous junction and conjunctiva epithelium as reported by Jalbert et al. in the electronic part of this issue. Fahnehjelm et al. in Sweden, UK, Finland and USA review the ocular findings in mucopolysaccharidosis in children. Loftsson et al. in Reykjavik discuss a novel ocular drug delivery platform based on cyclodextrin nano particles. Specifically they discuss the use of this drug delivery platform for the delivery of dorzolamide into the eye.
展开▼
